Related Experiment Videos

ACTH secreting pituitary microadenomas disclosed only by gadolinium DTPA enhanced MRI

B Boleaga1, G Fanghänel, L Cortinas

  • 1Hypothalamus-Hypophysis Clinic, Hospital General de México, D.F.

Abstract

Insights

Gadolinium-DTPA enhanced MRI is useful for detecting pituitary microadenomas in Cushing's disease patients. However, imaging may not fully capture the extent of pituitary abnormalities.

Area of Science:

  • Radiology
  • Endocrinology
  • Oncology

Background:

  • Cushing's disease is often caused by pituitary microadenomas.
  • Non-enhanced MRI may fail to detect small pituitary adenomas.
  • Accurate detection is crucial for effective treatment.

Purpose of the Study:

  • To evaluate the efficacy of Gadolinium-DTPA (Gd-DTPA) enhanced Magnetic Resonance Imaging (MRI) in identifying pituitary microadenomas.
  • To compare enhanced MRI findings with non-enhanced MRI in patients with Cushing's disease.

Main Methods:

  • Six patients with Cushing's disease underwent pre- and post-contrast enhanced MRI.
  • Surgical findings were correlated with MRI results.
  • Histological and immunohistochemistry studies confirmed surgical specimens.

Main Results:

  • Post-enhancement MRI successfully identified circumscribed hypointense foci corresponding to adenomas in all cases.
  • Two patients showed persistent clinical and laboratory abnormalities despite selective microadenoma removal.
  • Post-operative MRI in these two cases did not reveal residual hypointense foci.

Conclusions:

  • Gd-DTPA enhanced MRI is a valuable tool for detecting pituitary microadenomas.
  • Pituitary tissue abnormalities may extend beyond the visible imaging findings.
  • Further research is needed to understand the full extent of disease in Cushing's syndrome.

Related Concept Videos